Trial Profile
Bivalirudin as a primary anticoagulant in patients undergoing ventricular assist device (VAD)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Dec 2015
Price :
$35
*
At a glance
- Drugs Bivalirudin (Primary)
- Indications Thrombosis
- Focus Adverse reactions
- 16 Dec 2015 New trial record